Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-022225
Filing Date
2025-08-18
Accepted
2025-08-18 20:23:23
Documents
1
Period of Report
2025-08-14

Document Format Files

Seq Description Document Type Size
1 form4-08192025_120819.html 4  
1 form4-08192025_120819.xml 4 7984
  Complete submission text file 0001415889-25-022225.txt   9454
Mailing Address 3450 MONTE VILLA PARKWAY BOTHELL WA 98011
Business Address
Kaye Edward M. MD (Reporting) CIK: 0001522780 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38938 | Film No.: 251229399

Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Issuer) CIK: 0001623526 (see all company filings)

EIN.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)